A new analytic tool developed to assess safe use recommendations

Area of Science:

• Pharmacovigilance
• Health Informatics
• Drug Safety

Background:

• The Sentinel System is a key resource for post-market drug safety surveillance.
• Assessing adherence to safe drug use recommendations is crucial for patient outcomes.
• Existing methods may not adequately capture patient monitoring and concomitant medication use patterns.

Purpose of the Study:

• To develop a flexible analytic tool for the FDA's Sentinel System.
• To assess adherence to patient monitoring recommendations for specific drugs.
• To characterize concomitant medication use relative to drug therapy initiation and discontinuation.

Main Methods:

• Applied a newly developed analytic tool to the Sentinel Distributed Database.
• Assessed adherence to electrocardiogram (ECG) testing for dronedarone users.
• Evaluated concomitant contraception use for female mycophenolate users.

Main Results:

• 22% of 21,457 dronedarone users met the recommendation for ECGs every 3 months.
• 12% of 21,942 female mycophenolate users had concomitant contraception use for the recommended period.
• Younger females showed higher rates of concomitant contraception use.

Conclusions:

• A tool was developed for Sentinel Common Data Model databases to assess adherence to safe use recommendations.
• The tool can evaluate patient monitoring and concomitant drug use over time.
• Findings highlight potential gaps in adherence to specific drug safety guidelines.